Chimerix, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 1.83%59.640.0%$922.56m
AMGNAmgen, Inc. 0.36%259.171.3%$753.52m
GILDGilead Sciences, Inc. 0.67%76.861.0%$729.79m
REGNRegeneron Pharmaceuticals, Inc. 0.92%628.172.5%$665.49m
BIIBBiogen, Inc. 1.49%269.071.6%$567.38m
NVAXNovavax, Inc. -2.57%79.54102.0%$565.88m
VRTXVertex Pharmaceuticals, Inc. 0.12%291.461.9%$528.39m
ILMNIllumina, Inc. 2.05%380.753.5%$314.95m
ALXNAlexion Pharmaceuticals, Inc. 0.94%113.352.0%$230.59m
BMRNBioMarin Pharmaceutical, Inc. 0.59%127.524.3%$216.03m
SGENSeattle Genetics, Inc. 1.49%171.546.1%$205.31m
SRNESorrento Therapeutics, Inc. 4.66%7.171.8%$193.01m
IMMUImmunomedics, Inc. 9.03%40.9311.0%$173.97m
SRPTSarepta Therapeutics, Inc. 1.08%164.5113.9%$169.04m
INCYIncyte Corp. 1.24%107.792.5%$165.38m

Company Profile

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.